What Is MT-2 (Melanotan II)?

MT-2, or Melanotan II, is a synthetic cyclic peptide studied for its activity across the melanocortin receptor family. Where some analogues lean toward one receptor, MT-2 is generally described as engaging the family broadly, which is much of what makes it a reference compound in melanocortin pharmacology. This profile treats the molecule and its place in receptor research; it does not address use, and the pigmentation context the compound is known for in popular accounts sits outside what a research-use-only resource covers.

To see why MT-2 is studied, it helps to picture the receptors it acts on. The melanocortin receptors are a set of related receptors found in different tissues, each with its own distribution and signalling role, and together they form a small but varied family. Their natural ligands derive from a common precursor, of which alpha-MSH is one, so a molecule modelled on alpha-MSH naturally speaks to several of them.

That is what gives a broad agonist its research value. By engaging the family rather than a single member, MT-2 offers a way to study melanocortin signalling at the level of the whole family, and to serve as a comparison for analogues engineered to favour one receptor over the rest. The interest is in the receptors and the molecule’s reach across them, examined in the laboratory and nothing beyond it.

The molecule derives from alpha-melanocyte-stimulating hormone, the natural ligand of several melanocortin receptors. MT-2 is a shortened, cyclised analogue of that hormone, redesigned so that a compact ring reproduces the part of the natural signal the receptors recognise. The general business of assembling cyclic analogues of this kind is outlined in how peptides are manufactured.

Structurally MT-2 is small and closed into a ring, a form that gives it a constrained, well-defined shape and a measure of resistance to the enzymes that open linear chains. It is supplied as a lyophilised powder, listed as MT-2 in the catalogue, and the conventions for reading a cyclic sequence are covered in peptide sequence notation.

Research interest in MT-2 follows from the melanocortin receptors themselves, a family of related receptors with distinct roles. A peptide that engages them broadly is a useful tool for probing the family as a whole, which is the role MT-2 plays in laboratory study. The related cyclic analogue is profiled in what is PT-141?, and the wider range of signalling-research materials is in the research catalogue.

The deliberate use of that breadth deserves a closer look. A compound engaging the whole family behaves like a general probe of melanocortin signalling, while a selective analogue behaves like a targeted one, and researchers reach for whichever suits the question. MT-2 answers the broad question of what activating the family looks like, and is set beside narrower peptides when a single receptor must be isolated. Seen in that division of labour, its breadth is not a limitation but the specific quality it contributes to the toolkit.

MT-2 is widely associated in non-scientific sources with pigmentation. Those associations are deliberately left aside here: they concern use, and this resource is confined to the molecule as a research subject. Holding that line keeps the profile accurate and within the research-use-only remit the catalogue maintains.

The receptor mechanisms and the breadth of MT-2’s activity are taken up in the MT-2 research overview, and the practical care a robust cyclic peptide calls for is the subject of the MT-2 storage & handling guide.

All products are supplied strictly for laboratory research use only. Not for human or animal consumption. Not a drug, supplement, or food. Not for diagnostic or therapeutic use. The material on this page is educational and factual: it summarises areas of published scientific investigation and general laboratory practice. It is not guidance for the use of any material in humans or animals, and nothing here should be read as a claim about safety, performance, or outcomes. Where a specific product specification or safety data sheet is provided with a material, that document is the definitive reference and takes precedence over any general information given here.